Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Coram's suit blames Caremark for termination of Lincare merger; seeks $1.5 bil.

This article was originally published in The Gray Sheet

Executive Summary

CORAM SUIT BLAMES CAREMARK FOR DISSOLUTION OF LINCARE MERGER, alleging that "the termination was the direct and proximate result" of Caremark's "actions and omissions...which caused Coram to incur losses and to become financially weakened." The Denver-based alternate site infusion company's suit estimates damages resulting from the loss of the merger with Lincare Holdings to be worth $500 mil.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT004697

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel